Skip to main content

Table 2 Baseline characteristics of the enrolled participants based on their GGT quartiles

From: Gamma-glutamyl transferase levels are associated with the occurrence of post-stroke cognitive impairment: a multicenter cohort study

Characteristic

Total

GGT level

P-value

Q1(< 17.00)

Q2(17.00-24.00)

Q3(24.00-37.00)

Q4(≥37.00)

Laboratory test, median (IQR)

 Serum GGT, U/L

24.00(17.00-37.00)

13.00(11.00-15.00)

19.00(18.00-21.00)

28.20(26.00-31.80)

53.00(42.00-73.00)

< 0.001

 LDL, mmol/L

2.41(1.75-3.11)

2.36(1.79-3.03)

2.41(1.73-3.10)

2.43(1.66-3.08)

2.44(1.80-3.21)

0.49

 HDL, mmol/L

1.10(0.93-1.31)

1.18(1.00-1.40)

1.10(0.91-1.30)

1.08(0.91-1.26)

1.09(0.90-1.30)

< 0.001

 TC, mmol/L

4.10(3.35-4.87)

4.03(3.28-4.80)

4.05(3.34-4.73)

4.15(3.35-4.83)

4.20(3.46-5.11)

0.003

 TG, mmol/L

1.38(1.00-1.95)

1.10(0.85-1.54)

1.34(1.00-1.81)

1.45(1.09-2.14)

1.64(1.24-2.29)

< 0.001

 ALT, U/L

18.00(13.65-25.90)

14.10(11.90-19.00)

17.00(13.00-22.00)

19.00(14.00-26.00)

25.00(18.00-35.50)

< 0.001

 AST, U/L

19.00(16.00-24.00)

17.00(15.00-20.90)

18.00(15.00-23.00)

19.00(16.00-24.00)

21.60(17.00-28.00)

< 0.001

 eGFR, ml/min/1.73m2

95.11(84.94-103.56)

93.50(84.19-101.72)

94.20(84.43-103.25)

95.45(84.14-103.46)

97.71(88.10-105.75)

< 0.001

 UA, μmol/L

294.00(243.00-352.00)

264.00(224.00-322.00)

290.00(242.00-347.00)

298.00(247.00-353.00)

319.00(267.00-379.00)

< 0.001

 Albumin, g/L

40.60(38.10-43.00)

39.40(37.30-42.00)

40.50(38.00-42.70)

40.90(38.50-43.20)

41.25(39.00-43.80)

< 0.001

  1. Variables are expressed as median (s) or percentages. Q1, quartile 1 (n - 480): <17 U/L; Q2, quartile 2 (n - 455): 17-24 U/L; Q3, quartile 3 (n - 518): 24-37 U/L; Q4, quartile 4 (n - 504): ≥ 37 U/L. Cardiovascular diseases included atrial fibrillation, coronary heart disease, and heart failure. Medication use included drug use history and treatment during hospitalization. BMI body mass index, AIS acute ischemic stroke, TIA transient ischemic attack, NIHSS the National Institutes of Health Stroke Scale, mRS the modified Rankin Scale, TOAST the Trial of ORG 10172 in Acute Stroke Treatment, LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglycerides, TC total cholesterol, ALT alanine aminotransferase, AST aspartate aminotransferase, eGFR effective glomerular filtration rate, UA uric acid, IQR interquartile range